INMED PHARMACEUTICALS INC. (INM)

Import this data to Google Sheets with:

=jivedata("INM","financials")

Full statements spill as a table. For one cell: =jivedata("INM","Revenue") or =jivedata("INM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

INMED PHARMACEUTICALS INC.

INM • CIK 0001728328

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Research and Development Expense	$3,765.028	$2,853.92	$3,028.473	$3,028.473
General and Administrative Expense	$5,250.715	$6,557.822	$6,661.372	$6,661.372
Depreciation, Depletion and Amortization, Nonproduction	$219.6	$212.839	$205.271	$205.271
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-7,668.45	$-8,162.133	$-11,373.141	$-11,373.141
Gain (Loss) on Disposition of Assets	—	—	$-7.136	$-7.136
Income Tax Expense (Benefit)	$7.1	$7.1	—	$7.1
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	—	—	$-11,373.141	$-11,373.141
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$1,457.926	$1,457.926
Foreign Currency Transaction Gain (Loss), before Tax	—	$-28.471	$-58.009	$-58.009
Net Income (Loss) Attributable to Parent	$-7,675.55	$-8,162.133	$-12,560.85	$-12,560.85
Operating Expenses	$9,297.264	$9,653.052	$11,607.412	$11,607.412
Net Income (Loss) Available to Common Stockholders, Basic	—	—	$-12,992.514	$-12,992.514
Investment Income, Interest	$527.901	$155.882	$244.971	$244.971
Finance Lease, Interest Expense	—	$371.549	$10.7	$10.7
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	—	—	$-1,187.709	$-1,187.709
Weighted Average Number of Shares Outstanding, Basic	7,621,075	975,985	4,163,598	4,163,598

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$6,571.61	$11,075.871	$2,194.413	$2,194.413
Short-term Investments	$43.064	$43.384	$39.67	$39.67
Assets, Current	$8,689.585	$12,867.279	$2,676.706	$2,676.706
Prepaid Expense and Other Assets, Current	$477.749	$321.747	$241.296	$241.296
Assets Held-for-sale, Not Part of Disposal Group, Current	—	—	$20	$20
Assets	$11,822.782	$15,580.04	$3,030.067	$3,030.067
Disposal Group, Including Discontinued Operation, Assets, Current	—	—	$181.327	$181.327
Liabilities, Current	$1,971.808	$1,839.79	$1,955.06	$1,955.06
Liabilities	$2,616.673	$2,145.545	$1,955.06	$1,955.06
Stockholders' Equity Attributable to Parent	$9,206.109	$13,434.495	$1,075.007	$1,075.007
Property, Plant and Equipment, Net	$1,249.999	$992.199	$221.037	$221.037
Intangible Assets, Net (Excluding Goodwill)	$1,783.198	$1,620.562	$1,620.562	$0
Other Assets, Noncurrent	$100	$100	$132.324	$132.324
Accounts Payable and Accrued Liabilities, Current	$1,654.011	$1,404.283	$1,843.327	$1,843.327
Operating Lease, Liability, Current	$317.797	$435.507	$435.507	$389.381
Disposal Group, Including Discontinued Operation, Liabilities, Current	—	—	$111.733	$111.733
Operating Lease, Liability, Noncurrent	$644.865	$305.755	$305.755	$30.766
Common Stock, Value, Issued	$82,784.4	$91,221.174	$94,282.698	$94,282.698
Additional Paid in Capital, Common Stock	$35,368.899	$39,322.644	$36,894.146	$36,894.146
Retained Earnings (Accumulated Deficit)	$-109,075.759	$-117,237.892	$-130,230.406	$-130,230.406
Accumulated Other Comprehensive Income (Loss), Net of Tax	$128.569	$128.569	$128.569	$128.569
Common Stock, Shares, Issued	8,918,956	2,002,186	5,339,436	5,339,436

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Net Income (Loss) Attributable to Parent	$-7,675.55	$-8,162.133	$-12,560.85	$-12,560.85
Net Cash Provided by (Used in) Operating Activities	$-6,985.832	$-7,766.951	$-8,643.513	$-8,643.513
Net Cash Provided by (Used in) Investing Activities	$-9.293	$-9.293	—	$-9.293
Net Cash Provided by (Used in) Financing Activities	$4,654.218	$12,271.212	$94.496	$94.496
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	—	$4,504.261	$-8,549.017	$-8,549.017
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$6,571.61	$11,075.871	$2,194.413	$2,194.413
Depreciation, Depletion and Amortization	$219.6	$212.839	$205.271	$205.271
Share-based Payment Arrangement, Noncash Expense	$137.714	$119.307	$106.866	$106.866
Operating Lease, Right-of-Use Asset, Amortization Expense	$384.918	$321.885	$503.085	$503.085
Gain (Loss) on Disposition of Property Plant Equipment	—	—	$-7.136	$-7.136
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$1,457.926	$1,457.926
InterestIncomeShortTermInvestmentOther	$1.25	—	$1.073	$1.073
Foreign Currency Transaction Gain (Loss), Unrealized	$-61.921	—	$-7.151	$-7.151
Increase (Decrease) in Prepaid Expense and Other Assets	—	—	$-83.038	$-83.038
Proceeds from Sale of Short-term Investments	$42.082	$42.27	$41.34	$41.34
Increase (Decrease) in Other Noncurrent Assets	$-4.908	$-4.908	$32.324	$32.324
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$45.282	$-249.728	$618.679	$618.679
IncreaseDecreaseInOperatingLeaseLiability	$-397.422	$-429.88	$-745.529	$-745.529
Cash Provided by (Used in) Operating Activities, Discontinued Operations	—	—	$1,517.886	$1,517.886
Proceeds from Warrant Exercises	$0.175	$0.175	$5,024.891	$5,024.891
Proceeds from Issuance of Warrants	$3,500	$5,024.891	$231.675	$231.675
Payments of Stock Issuance Costs	—	$883.978	$137.179	$137.179
Income Taxes Paid	$7.1	$7.1	—	$7.1

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("INM","financials")

Full statements spill as a table. For one cell: =jivedata("INM","Revenue") or =jivedata("INM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.